First Time Loading...

Genocea Biosciences Inc
NASDAQ:GNCA

Watchlist Manager
Genocea Biosciences Inc Logo
Genocea Biosciences Inc
NASDAQ:GNCA
Watchlist
Price: 0.0002 USD -33.33% Market Closed
Updated: May 7, 2024

Genocea Biosciences Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genocea Biosciences Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Genocea Biosciences Inc
NASDAQ:GNCA
Cash from Financing Activities
$6m
CAGR 3-Years
-52%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
$21B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-88%
CAGR 10-Years
N/A

See Also

What is Genocea Biosciences Inc's Cash from Financing Activities?
Cash from Financing Activities
6m USD

Based on the financial report for Dec 31, 2021, Genocea Biosciences Inc's Cash from Financing Activities amounts to 6m USD.

What is Genocea Biosciences Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
36%

Over the last year, the Cash from Financing Activities growth was -93%. The average annual Cash from Financing Activities growth rates for Genocea Biosciences Inc have been -52% over the past three years , 36% over the past five years .